TP53 and cancer: Multiple reports with experimental evidence show that the efficacy of various chemotherapeutic agents, including cisplatin, requires a functional TP53 protein for efficient induction of apoptosis and that loss of TP53 function enhances resistance to cytotoxic agents used in cancer therapy [29,30,31].